COVOVAX Vaccine By Serum Institute of India Gets Emergency Approval From WHO

Covovax Vaccine by the Serum Institute of India [SII] gets the approval from the WHO for emergency use. Under the license from Novavax, Covovax will be produced in India by the SII. It is a part of COVAX, a worldwide initiative aimed at providing, equitable access to COVID-19 vaccines. Moving ahead in this direction the WHO issuing emergency use listing of the Covovax is a step in expanding the basket of jabs validated by the global health body against Corona. As a result of this step by the WHO Covovax becomes the 9th vaccine to be listed. Meanwhile Adar Poonawalla tweets, "This is yet another milestone in our fight against COVID-19, showing excellent safety and efficacy. Thank you all for a great collaboration." Indeed its a great news among the rising cases of Omicron variant across...

Read More